South Plainfield, NJ -- October 7, 2013 -- GENEWIZ, Inc. leading global genomic service provider, has now become an Ion AmpliSeq™ Exome Certified Service Provider.
Administered by Life Technologies, "[the] Ion AmpliSeq™ Exome Certified Service Provider Program is a network of validated service providers that enables any researcher to get high quality exome sequence, using small amounts of input material and with rapid turnaround."
With the Ion Proton™, GENEWIZ can deliver exome sequencing and RNA-Seq projects rapidly and cost-effectively, without the requirement of multiplexing large numbers of samples per run.
"As a full-service next generation sequencing provider, offering services on the Ion Proton™ enables GENEWIZ to best optimize experiments based on our customers’ project needs," stated Ginger Zhou, Head of NGS (U.S.), GENEWIZ, Inc. "As an Ion AmpliSeq™ Exome Certified Service Provider, we can deliver high-quality results in as few as 7 business days. In addition to rapid results, this certification endorses the consistent level of quality data and service customers can count on from GENEWIZ."
About GENEWIZ, Inc.
GENEWIZ, Inc. is a global contract research organization (CRO) specializing in genomic services, including DNA sequencing, gene synthesis, molecular biology, genomic, bioinformatics, and GxP/CLIA regulatory-compliant services. GENEWIZ leads the industry in outsourcing partnerships with pharmaceutical, biotechnology, clinical, academic, and government institutions.
Headquartered in South Plainfield, NJ, GENEWIZ, Inc. is a privately-held global enterprise with locations in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; London, United Kingdom; and Tokyo, Japan.